STOCK TITAN

CRA International (CRAI) Form 4 Filings

CRAI NASDAQ

Every Form 4 that CRA International, Inc. (CRAI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CRAI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CRAI filings page.

Rhea-AI Summary

CRA International EVP and General Counsel Jonathan D. Yellin reported multiple equity compensation transactions dated March 2, 2026. He was granted 1,085.7412 restricted stock units and 1,067 shares of common stock at a stated price of $0.0000 per share. To cover tax obligations, 344 shares of common stock were disposed of at $180.2600 per share, along with a separate 19.7415-share disposition to the issuer, leaving him with 16,296 common shares directly owned. Footnotes describe how various RSU awards, including associated dividend units, will vest in scheduled annual installments beginning on several dates in 2026 and 2027.

Rhea-AI Summary

CRA International president and CEO Paul A. Maleh reported multiple equity compensation transactions in the form of stock and unit awards. On March 2, 2026, he acquired 5,366.5364 restricted stock units tied to performance restricted stock units granted on April 29, 2024, and received 5,267 shares of common stock issued upon vesting of those performance awards. He also acquired an additional 97.5136 shares of common stock as related dividend units.

To cover tax obligations, 1,559 shares of common stock were disposed of at $180.26 per share through share delivery, and 97.5136 shares were returned to the issuer at the same price. Following these transactions, he directly held 120,253 shares of common stock, along with several blocks of restricted stock units and nonqualified stock options that vest in annual installments beginning in 2026 and 2027.

Rhea-AI Summary

CRA International, Inc. executive vice president Chad M. Holmes reported a mix of equity awards and related share withholdings on March 2, 2026. He received 1,022.5936 restricted stock units (RSUs) and grants of 1,004 and 18.5707 shares of common stock, all at a stated price of $0.00 per share as compensation awards.

To cover taxes on vesting, 506 common shares were disposed of at $180.26 per share, and 18.5707 shares were surrendered to the issuer at the same price. Following these transactions, Holmes directly held 45,356 shares of common stock, plus multiple RSU and stock option positions that vest between 2026 and 2027 as described in the footnotes.

Rhea-AI Summary

CRA International, Inc. reported insider equity holdings for an officer serving as EVP and General Counsel. Following transactions dated December 12, 2025, the officer directly beneficially owns 15,573 shares of common stock.

The disclosure lists multiple restricted stock unit awards that vest on specific dates, including grants that vest on March 10, 2026 and others that vest in equal annual installments beginning on April 11, April 29, and May 20, 2026. These RSUs include additional dividend-equivalent units that are credited when dividends are paid on the company’s common stock.

The officer also holds nonqualified stock options to purchase 2,377 shares at $44.87 per share expiring on December 18, 2027, and 2,845 shares at $47.45 per share expiring on December 6, 2028.

Rhea-AI Summary

CRA International, Inc. reported that its executive vice president, chief financial officer and treasurer acquired restricted stock units (RSUs) on December 12, 2025. The RSUs carry an exercise price of $0, and following this transaction the officer beneficially owns 737.9104 RSUs tied to the company’s common stock.

Each RSU represents a contingent right to receive one share of common stock, payable in cash, shares, or a combination after vesting and tax withholding. The RSUs, which include 3.9104 dividend-equivalent units, are scheduled to vest in four equal annual installments beginning on August 4, 2026, with dividend equivalents accruing as additional RSUs and vesting on the same schedule.

Rhea-AI Summary

CRA International, Inc. reported that its President and CEO, who also serves as a director, received several restricted stock unit (RSU) awards on 12/12/2025. Each RSU represents a contingent right to receive one share of common stock, payable in cash, shares, or a combination, and accrues additional RSUs as dividend equivalent rights when dividends are paid.

The new RSU grants include Dividend Units such as 88.4555, 127.3641, 99.3368, 174.3620, 78.6585 and 35.3720 units in different awards, with vesting dates on March 10, 2026 and in annual installments beginning April 11, 2026, April 29, 2026 and May 20, 2026. After these transactions, the reporting person beneficially owned 116,545 shares of common stock directly, as well as nonqualified stock options covering 16,304 shares at an exercise price of $44.87 and 15,173 shares at $47.45.

Rhea-AI Summary

CRA International, Inc. reported an executive equity award involving restricted stock units (RSUs) linked to its common stock. On December 12, 2025, the reporting officer acquired 2.0954 RSUs, and following this transaction beneficial ownership increased to 737.9104 RSUs, held directly.

Each RSU represents a contingent right to receive one share of CRA International common stock and may be settled in cash, shares, or a combination. Shares, when issued, are delivered as soon as possible after vesting and no later than two and one-half months after the end of the year in which vesting occurs, subject to tax withholding. Dividend equivalent rights accrue on unvested RSUs as additional RSUs, called Dividend Units, which vest on the same schedule. The RSUs, which include an aggregate of 3.9104 Dividend Units, vest in four equal annual installments beginning on August 4, 2026.

Rhea-AI Summary

CRA International's EVP and chief corporate development officer reported updated equity holdings as of 12/12/2025. The filing shows beneficial ownership of 44,858 shares of common stock held directly.

The executive also reports several blocks of restricted stock units, with post-transaction balances including 459.7215 and 662.8693 units, each representing a contingent right to receive one share of common stock and accruing dividend equivalent units that vest on the same schedule. These RSUs vest on dates ranging from March 10, 2026 to May 20, 2026, some in equal annual installments. In addition, the report lists nonqualified stock options to purchase 4,076 shares at $44.87 expiring on 12/18/2027 and 4,425 shares at $47.45 expiring on 12/06/2028, each originally granted to vest in four equal annual installments beginning one year after grant.

Rhea-AI Summary

A director of CRA International, Inc. reported a small sale of company stock. On 12/11/2025, the director sold 110 shares of common stock at a price of $198.12 per share, coded as a sale transaction ("S"). After this trade, the director beneficially owns 2,941 shares of CRA International common stock in direct ownership.

The company notes that this transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025, which is designed to allow scheduled trading of shares under specified conditions.

Rhea-AI Summary

CRA International, Inc. (CRAI) executive vice president and general counsel reported multiple open-market sales of company common stock. On 11/20/2025, the reporting person sold 1,317 shares at a weighted average price of $174.1586, 343 shares at $174.8737, 60 shares at $175.4279, and 30 shares at $176.3925, all coded as sales.

After these transactions, the reporting person beneficially owned 15,573 shares of CRA International common stock held directly. The filing notes that all transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on August 8, 2024, and that the prices shown are weighted averages for trades executed within specified intraday price ranges.